Clinical Trials Related to Cyclophosphamide

Related studies linked through entity extraction aliases.

A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participants With Untreated BCL-2 Immunohistochemistry (IHC)-Positive Diffuse Large B-Cell Lymphoma (DLBCL)

Status: TERMINATED
Phase: PHASE1

Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia

Status: TERMINATED
Phase: PHASE1

Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab

Status: RECRUITING
Phase: PHASE1/PHASE2

Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies

Status: WITHDRAWN
Phase: EARLY_PHASE1

MicroRNA Profiles in Triple Negative Breast Cancer

Status: RECRUITING
Phase: PHASE2

Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy

Status: TERMINATED
Phase: PHASE2

LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer

Status: WITHDRAWN
Phase: PHASE1

Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients

Status: RECRUITING
Phase: PHASE3

Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Status: TERMINATED
Phase: PHASE1/PHASE2

PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy

Status: RECRUITING
Phase: PHASE2

Different Immunosuppressive Treatment in iMN

Status: RECRUITING
Phase: PHASE3

A Phase 1 Study of ADI-001 in B Cell Malignancies

Status: TERMINATED
Phase: PHASE1

Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer

Status: UNKNOWN
Phase: PHASE2

FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia

Status: COMPLETED
Phase: PHASE1

Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Status: UNKNOWN
Phase: PHASE2